X-COR Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- X-COR Therapeutics's estimated annual revenue is currently $753k per year.
- X-COR Therapeutics's estimated revenue per employee is $125,500
- X-COR Therapeutics's total funding is $2.8M.
Employee Data
- X-COR Therapeutics has 6 Employees.
- X-COR Therapeutics grew their employee count by -14% last year.
X-COR Therapeutics's People
| Name | Title | Email/Phone |
|---|
X-COR Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $8.5M | 34 | 3% | N/A | N/A |
#3 | $3M | 12 | -29% | N/A | N/A |
#4 | $5630M | 7477 | -11% | $450M | N/A |
#5 | $4.5M | 18 | 6% | N/A | N/A |
#6 | $7.2M | 57 | 27% | $29.6M | N/A |
#7 | $14.3M | 57 | -12% | N/A | N/A |
#8 | $2.3M | 18 | 6% | $44M | N/A |
#9 | $40.7M | 162 | -1% | N/A | N/A |
#10 | $45.7M | 182 | -5% | N/A | N/A |
What Is X-COR Therapeutics?
X-COR Therapeutics is a Boston based medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure.
keywords:N/A
$2.8M
Total Funding
6
Number of Employees
$753k
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
X-COR Therapeutics News
2022-04-20 - Inflammasome activation in infected macrophages drives ...
... in lungs of infected MISTRG6-hACE2 in response to therapeutics. ... based on Pearson's product-moment correlation coefficient cor(x,...
Other Companies in Allston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 13 | -50% | N/A |
#2 | $2.3M | 15 | -53% | N/A |
#3 | $1.2M | 16 | 33% | N/A |
#4 | $2.6M | 17 | 6% | N/A |
#5 | $3.5M | 21 | 5% | N/A |